Plenvu
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Colorectal Cancer
Conditions
Colorectal Cancer
Trial Timeline
Mar 11, 2020 → Jun 28, 2022
NCT ID
NCT04297423About Plenvu
Plenvu is a approved stage product being developed by Recordati for Colorectal Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT04297423. Target conditions include Colorectal Cancer.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04297423 | Approved | Completed |
Competing Products
20 competing products in Colorectal Cancer